Human Bcl-2 antisense therapy for lymphomas (Q33916124)

30 July 2017

1 reference

title

Human Bcl-2 antisense therapy for lymphomas (English)

1 reference

30 July 2017

3

D Cunningham

1 reference

30 July 2017

F E Cotter

1

1 reference

PubMed ID

10807000

30 July 2017

J Waters

series ordinal

2

1 reference

PubMed ID

10807000

30 July 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

Biochimica et Biophysica Acta

30 July 2017

1 reference

30 July 2017

1489

1 reference

30 July 2017

1

1 reference

30 July 2017

97-106

1 reference

Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900139-6

7 January 2021

Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900139-6

7 January 2021

Inhibition of human immunodeficiency virus replication by antisense oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900139-6

7 January 2021

Specific regulation of gene expression by antisense, sense and antigene nucleic acids

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900139-6

7 January 2021

Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900139-6

7 January 2021

Implication of RNA structure on antisense oligonucleotide hybridization kinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900139-6

7 January 2021

Small noncleaved, non-Burkitt's (Burkit-Like) lymphoma: cytogenetics predict outcome and reflect clinical presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900139-6

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900139-6

7 January 2021

Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900139-6

7 January 2021

Evaluation of bcl-2 protein expression and 14;18 translocation as prognostic markers in follicular lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900139-6

7 January 2021

BCL-2 expression by leukaemic blasts in a SCID mouse model of biphenotypic leukaemia associated with the t(4;11)(q21;q23) translocation.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900139-6

7 January 2021

BCL2-mediated tumorigenicity of a human T-lymphoid cell line: synergy with MYC and inhibition by BCL2 antisense

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900139-6

7 January 2021

ChlVPP combination chemotherapy for Hodgkin's disease: long-term results

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900139-6

7 January 2021

Expression of the bcl-2 protooncogene in the cycling adult mouse hair follicle

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900139-6

7 January 2021

Selective Inhibition of Leukemia Cell Proliferation by BCR-ABL Antisense Oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900139-6

7 January 2021

Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900139-6

7 January 2021

BCL-2 antisense therapy in patients with non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900139-6

7 January 2021

Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900139-6

7 January 2021

10.1016/S0167-4781(99)00139-6

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10807000